share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director HERSHBERG ROBERT

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director HERSHBERG ROBERT

Recursion Pharmaceuticals | 4:持股变动声明-董事 HERSHBERG ROBERT
美股sec公告 ·  06/05 18:17
Moomoo AI 已提取核心信息
Robert Hershberg, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a stock transaction on June 3, 2024. The transaction involved a grant of 13,097 shares of Class A Common Stock at no cost. Following the transaction, Hershberg's direct holdings in the company increased to a total of 51,716 shares. The grant is part of the company's compensation strategy and reflects the ongoing commitment to align the interests of its executives with those of shareholders.
Robert Hershberg, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a stock transaction on June 3, 2024. The transaction involved a grant of 13,097 shares of Class A Common Stock at no cost. Following the transaction, Hershberg's direct holdings in the company increased to a total of 51,716 shares. The grant is part of the company's compensation strategy and reflects the ongoing commitment to align the interests of its executives with those of shareholders.
2024年6月3日,与Recursion Pharmaceuticals,Inc.[RXRX]有关的Robert Hershberg完成了一笔股票交易。该交易涉及授予13,097股A类普通股,不收取费用。交易后,Hershberg在公司的直接持股增加到总共51,716股。该授予是公司薪酬策略的一部分,反映出与股东的利益保持一致的执行人员的持续承诺。
2024年6月3日,与Recursion Pharmaceuticals,Inc.[RXRX]有关的Robert Hershberg完成了一笔股票交易。该交易涉及授予13,097股A类普通股,不收取费用。交易后,Hershberg在公司的直接持股增加到总共51,716股。该授予是公司薪酬策略的一部分,反映出与股东的利益保持一致的执行人员的持续承诺。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息